Investor Presentaiton
CORPORATE CENTRE
Revenues
Q4 22 revenues impacted by changes in fair value
of the instruments used to hedge the equity
stakes in subsidiaries
Base effect vs. Q4 21 mainly due to the
revaluation of one asset (EUR 117m)
Operating expenses
EUR -177m (2) transformation charges in Q4 22
EUR -639m (3) transformation charges in 2022
Other items
Base effect vs. Q4 21 mainly due to capital gain
on Lyxor sale (EUR 439m)
Impact of the disposal of the Russian activities
in 2022 (EUR -3.3bn)
In EURM
Q422
Q421
2022
2021
Net banking income
(155)
93
16
374
Underlying net banking income(¹)
(155)
(24)
16
257
Operating expenses
(324)
(387)
(1,189)
(889)
Underlying operating expenses(¹)
(160)
(251)
(550)
(510)
Gross operating income
(479)
(294)
(1,173)
(515)
Underlying gross operating income (¹)
(315)
(275)
(534)
(253)
Net cost of risk
17
(7)
(38)
(6)
(60)
429
(3,364)
603
31
193
516
187
Reported Group net income
Underlying Group net income (¹)
(502)
168
(4,230)
(9)
(333)
(255)
(633)
(386)
Net profits or losses from other assets
Income tax
(1) Underlying data: adjusted for exceptional items and IFRIC 21 linearisation (see Supplement), (2) Q4 22 transformation charges: French Retail Banking (EUR 69m), Global Banking and Investor Solutions (EUR 54m) and Corporate Center (EUR 54m),
(3) 2022 transformation charges: French Retail Banking (EUR 370m), Global Banking and Investor Solutions (EUR 117m) and Corporate Center (EUR 152m)
SOCIETE
GENERALE
4TH QUARTER AND FULL YEAR 2022 RESULTS 18 FEBRUARY 2023View entire presentation